Recombinant Glycosylated canine (dog) PAI-1 Wild Type Latent Fraction

• Cat.No.: SERPINE1 -86D
• Product Overview: Glycosylated wild type dog PAI-1 produced in insect cells. Latent form.

Specification

• Source: Insect cell
• Species: Dog
• Form: Frozen liquid
• Molecular Mass: 46,000
• Purity: >95% by SDS-PAGE analysis
• Usage: For in vitro laboratory use only
• Notes: Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet.
• Storage: -70°C
• Concentration: 1.0 mg/ml
• Storage Buffer: 0.05M Sodium Acetate; 0.1M NaCl; 1mM EDTA; pH 5.0
• Shipping: Dry ice

Gene Information

• Gene Name: SERPINE1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 [ Canis lupus familiaris ]
• Official Symbol: SERPINE1
• Synonyms: SERPINE1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; plasminogen activator inhibitor 1; plasminogen activator inhibitor type 1; PAI-1
• Gene ID: 403476
• mRNA Refseq: NM_001197095
• Protein Refseq: NP_001184024
• Chromosome Location: chromosome: 6
• Pathway: Blood Clotting Cascade, organism-specific biosystem; Chagas disease (American trypanosomiasis), organism-specific biosystem; Chagas disease (American trypanosomiasis), conserved biosystem; Complement and coagulation cascades, organism-specific biosystem; Complement and coagulation cascades, conserved biosystem; Dissolution of Fibrin Clot, organism-specific biosystem; Hemostasis, organism-specific biosystem